Overview

Efficacy of Inhaled Cannabis for Acute Migraine Treatment

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This crossover study will evaluate 3 different treatments of vaporized cannabis (THC, THC/CBD mix, and CBD) and vaporized placebo cannabis for the acute treatment of migraine.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
Migraine Research Foundation
Treatments:
Cannabidiol
Dronabinol
Epidiolex